Compare Stocks: CYTR, DWMC, and CHNA

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CHNA Loncar China Biopharma ETF	$13.53 -0.1%	$13.95	$13.35 ▼ $22.89	$3.79M	0.67	538 shs	100 shs
CYTR LadRx		$0.09	$0.05 ▼ $0.86	$4.14M	N/A	99,706 shs	4,000 shs
DWMC AdvisorShares Dorsey Wright Micro-Cap ETF	$30.95 -0.3%	$31.46	$29.67 ▼ $34.85	$2.48M	1.15	879 shs	100 shs

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CHNA Loncar China Biopharma ETF	0.00%	0.00%	0.00%	0.00%	-27.38%
CYTR LadRx	0.00%	0.00%	0.00%	0.00%	0.00%
DWMC AdvisorShares Dorsey Wright Micro-Cap ETF	0.00%	0.00%	0.00%	0.00%	+1.13%

Healthcare Takes A Big Step Forward With The Help Of AI (Ad)

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CHNA Loncar China Biopharma ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CYTR LadRx	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
DWMC AdvisorShares Dorsey Wright Micro-Cap ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CHNA Loncar China Biopharma ETF	0.00	N/A	$31.74	134.56% Upside
CYTR LadRx	N/A	N/A	N/A	N/A
DWMC AdvisorShares Dorsey Wright Micro-Cap ETF	0.00	N/A	$39.04	26.15% Upside

Current Analyst Ratings

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CHNA Loncar China Biopharma ETF	N/A	N/A	N/A	N/A	N/A	N/A
CYTR LadRx	N/A	N/A	N/A	N/A	N/A	N/A
DWMC AdvisorShares Dorsey Wright Micro-Cap ETF	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CHNA Loncar China Biopharma ETF	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
CYTR LadRx	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
DWMC AdvisorShares Dorsey Wright Micro-Cap ETF	N/A	N/A	7.50	∞	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CHNA Loncar China Biopharma ETF	$0.06	0.44%	N/A	N/A	N/A
CYTR LadRx	N/A	N/A	N/A	N/A	N/A
DWMC AdvisorShares Dorsey Wright Micro-Cap ETF	$0.25	0.81%	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
CHNA Loncar China Biopharma ETF	N/A
CYTR LadRx	N/A
DWMC AdvisorShares Dorsey Wright Micro-Cap ETF	N/A

Insider Ownership

Company	Insider Ownership
CHNA Loncar China Biopharma ETF	N/A
CYTR LadRx	N/A
DWMC AdvisorShares Dorsey Wright Micro-Cap ETF	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
CHNA Loncar China Biopharma ETF	147,000	1.43 million	N/A	Not Optionable
CYTR LadRx	N/A	45.04 million	N/A	Not Optionable
DWMC AdvisorShares Dorsey Wright Micro-Cap ETF	147,000	80,000	N/A	Not Optionable

CYTR, DWMC, and CHNA Headlines

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Company Descriptions

Loncar China Biopharma ETF

NASDAQ:CHNA

The Loncar China BioPharma ETF (CHNA) is an exchange-traded fund that is based on the Loncar China BioPharma index. The fund tracks a tier-weighted index of companies directly involved in the growth of Chinas pharmaceutical and biotech industry. CHNA was launched on Aug 14, 2018 and is managed by Loncar.

LadRx

NASDAQ:CYTR

LadRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded in 1985 and is headquartered in Los Angeles, CA.

AdvisorShares Dorsey Wright Micro-Cap ETF

NASDAQ:DWMC

The AdvisorShares Dorsey Wright Micro-Cap ETF (DWMC) is an exchange-traded fund that is based on the Russell 3000 index. The fund is an actively managed portfolio of US-listed micro-cap stocks. The fund follows a rules-based momentum strategy and seeks long-term capital appreciation. DWMC was launched on Jul 10, 2018 and is managed by AdvisorShares.

Compare Stocks